NCT02339077

Brief Summary

This is a descriptive study to determine the role of fetal GBS disease as a cause for stillbirths

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
354

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2014

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2014

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 15, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

May 28, 2024

Status Verified

September 1, 2018

Enrollment Period

1 year

First QC Date

August 11, 2014

Last Update Submit

May 23, 2024

Conditions

Keywords

Group B Streptococcus, stillborn

Outcome Measures

Primary Outcomes (1)

  • Determine the number of stillbirths who have GBS isolated from cord blood, gastric aspirates, placenta and/ or skin swabs

    Birth

Secondary Outcomes (2)

  • Number of stillbirths occurring at CHBAH, and identify potential causes of the stillbirths (maternal and obstetric risk factors)

    Birth

  • Number of stillbirths related to a probable Infectious cause

    Birth

Eligibility Criteria

AgeUp to 1 Day
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Stillborn infants (gestational age \>= 28 weeks gestation) born at CHBAH

You may qualify if:

  • Pregnant women delivering a stillbirth at CHBAH
  • Participants aged ≥18 years
  • Able to understand and comply with planned study procedures
  • Provides written informed consent (either generic ICF or V98\_28OBTP)

You may not qualify if:

  • Refuses to consent to study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Respiratory and Meningeal Pathogen Research Unit

Johannesburg, Gauteng, 2013, South Africa

Location

Chris Hani Baragwanath Academic Hospital

Johannesburg, Gauteng, South Africa

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Cord blood Placenta skin swab from fetus Gastric/ tracheal aspirate

MeSH Terms

Conditions

Stillbirth

Condition Hierarchy (Ancestors)

Fetal DeathPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

August 11, 2014

First Posted

January 15, 2015

Study Start

October 1, 2014

Primary Completion

October 1, 2015

Study Completion

December 1, 2015

Last Updated

May 28, 2024

Record last verified: 2018-09

Locations